WOCKHARDT BIO AG More news
| Managers | Title | Age | Since |
|---|---|---|---|
Ajay Sahni
CEO | Chief Executive Officer | 57 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 85 | 19-03-31 | |
Ajay Sahni
CEO | Chief Executive Officer | 57 | 07-12-31 |
Ravi Limaye
BRD | Director/Board Member | 60 | - |
Wockhardt Bio AG is a Germany-based pharmaceutical company. It is active in the development, manufacturing and marketing of pharmaceutical and biopharmaceutical formulations. It offers a portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and forms. Its offering covers several therapeutic categories, such as central nervous system agents, hormones, cardiovascular agents, anti-infective and respiratory agents, as well as gastrointestinal, dermatological and biological agents. The Company supplies markets in the United States, the United Kingdom, Ireland, France and Latin America. Additionally, it exports its pharmaceutical products to over 50 countries.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +18.37% | 42.77B | |
| +20.21% | 22.23B | |
| +13.19% | 14.44B | |
| +12.00% | 13.05B | |
| +35.95% | 11.59B | |
| -8.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +5.03% | 4.97B |
